相关实验视频

Updated: Sep 8, 2025

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

通过USP9X/MCL1介导的线粒体稳定,Tectorigenin减轻心脏缩

Xiaoqiang Chen¹, Genqing Zhou², Tianyou Yuan²

¹Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Fujian Branch of National Clinical Research Center for Cardiovascular Diseases, Xiamen, China.

|September 5, 2025

概括

通过USP9X-MCL1通路稳定线粒体完整性,Tectorigenin (Tec) 能够防止心脏缩. 这种天然化合物为心力衰竭提供了一种新的以线粒体为中心的治疗策略.

科学领域:

心血管生物学
线粒体医学
药理学

背景情况:

病理性心脏缩是一个主要的治疗挑战,通常是由线粒体功能障碍和不适应性重塑驱动的.
目前治疗心脏缩的方法在解决潜在的线粒体问题方面存在局限性.

研究的目的:

在横向大动脉收缩 (TAC) 引起的心脏缩中研究构造素 (Tec) 的心脏保护作用.
阐明潜在的分子机制,特别关注线粒体平衡和USP9X-MCL1轴.

主要方法:

使用TAC诱导的心脏缩的小鼠模型的体内研究.
在体外实验中使用烯酸刺激心肌细胞.
线粒体功能,细胞大小,纤维化和蛋白质表达的分析 (MCL1,USP9X).
基因沉默技术来评估MCL1和USP9X的作用.

主要成果:

在TAC小鼠中,TAC的使用改善了存活率,减少了心脏功能障碍,增生和纤维化.
在实验室中,Tec抑制了心肌细胞扩大和线粒体功能障碍.
通过USP9X介导的双化,TEC稳定了线粒体蛋白MCL1,独立于PI3K- AKT信号.
沉默MCL1或USP9X取消了Tec的保护作用.

结论:

对病理性缩具有显著的心脏保护作用.
通过一种新型的USP9X-MCL1-线粒体轴来维持线粒体的完整性.
它代表了一种有希望的针对线粒体的治疗策略,与传统的生存途径不同.

关键词:

其他类型线粒体功能障碍病理性心脏缩德克托基因在地化

更多相关视频

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Published on: September 25, 2017

Transverse Aortic Constriction in Mice

Transverse Aortic Constriction in Mice

Published on: April 21, 2010

相关概念视频

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...